Press Release PathoQuest Receives GMP Certification for its NGS-based Quality Control Testing Services Pour la version en français de ce communiqué de presse : cliquez ici PARIS, FRANCE – November 24, 2021 – PathoQuest, a leading contract research organization (CRO)...
Press Release PathoQuest closes up to €15 million Series B financing round led by growth investor SHS Capital Pour la version en français de ce communiqué de presse : cliquez ici This funding round allocated in tranches will strengthen PathoQuest’s position as a...
Press Release PathoQuest, recipient of French Investment Program, expands NGS-based portfolio of quality control tests for biologics Pour la version en français de ce communiqué de presse : cliquez ici Paris, FRANCE – October 25, 2021 – PathoQuest, a pioneer in the...
Press Release PathoQuest Appoints Eric Cazergue as Chief Financial Officer Pour la version en français de ce communiqué de presse : cliquez ici PARIS, FRANCE — April 06, 2021 – PathoQuest, a pioneer of Next Generation Sequencing (NGS)-based testing solutions for...
Press Release PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary Pour la version en français de ce communiqué de presse : cliquez ici WAYNE, PA, and PARIS, FRANCE – March 18, 2021 – PathoQuest, a pioneer in...
Press Release PathoQuest signs agreement with Massachusetts Institute of Technology (MIT) to join Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) as NGS viral safety expert Pour la version en français de ce communiqué de presse : cliquez ici...
